Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis

Antimicrobial Agents and Chemotherapy
Kimberley A SavagePaul L Fidel

Abstract

Candida albicans is an important opportunistic pathogen causing various human infections that are often treated with azole antifungals. The U.S. CDC now regards developing candidal antifungal resistance as a threat, creating a need for new and more effective antifungal treatments. Iron is an essential nutrient for all living cells, and there is growing evidence that interference with iron homeostasis of C. albicans can improve its response to antifungals. This study was aimed at establishing whether withholding iron by currently used medical iron chelators and the novel chelator DIBI could restrict growth and also enhance the activity of azoles against clinical isolates of C. albicans DIBI, but not deferoxamine or deferiprone, inhibited the growth of C. albicans at relatively low concentrations in vitro, and this inhibition was reversed by iron addition. DIBI in combination with various azoles demonstrated stronger growth inhibition than the azoles alone and greatly prolonged the inhibition of cell multiplication. In addition, the administration of DIBI along with fluconazole (FLC) to mice inoculated with an FLC-sensitive isolate in a model of experimental C. albicans vaginitis showed a markedly improved clearance of infection....Continue Reading

References

May 1, 1971·Annals of Internal Medicine·N J Greenberger
Mar 20, 1966·Journal of the American Chemical Society·W A Baker, P M Brown
Jul 1, 1997·Antimicrobial Agents and Chemotherapy·P L FidelJ D Sobel
Jan 9, 1998·Infectious Disease Clinics of North America·A Espinel-Ingroff
Aug 4, 1998·Antimicrobial Agents and Chemotherapy·G S Baillie, L J Douglas
Feb 24, 2001·Drugs·G Garber
Jul 27, 2002·Annual Review of Microbiology·Leah E CowenLinda M Kohn
Jun 14, 2003·The Journal of Antimicrobial Chemotherapy·F C Odds
Feb 16, 2006·Journal of Medical Microbiology·John J BullenC Gillon Ward
Jan 16, 2007·Clinical Microbiology Reviews·M A Pfaller, D J Diekema
Jun 15, 2007·Lancet·Jack D Sobel
Sep 28, 2007·Acta Microbiologica Et Immunologica Hungarica·Nagendra Nath MishraRandhir Singh
Oct 2, 2007·Microbiology·Richard D CannonBrian C Monk
Dec 15, 2007·Nature Reviews. Microbiology·Mihai G NeteaNeil A R Gow
Aug 5, 2008·Biochimica Et Biophysica Acta·Eugene D Weinberg
Jul 15, 2009·Recent Patents on Anti-infective Drug Discovery·Mathieu BalloucheChristine Baysse
Apr 21, 2010·FEMS Microbiology Letters·Bruce E Holbein, Ramón Mira de Orduña
Aug 17, 2010·Current Opinion in Critical Care·Maiken C Arendrup
Oct 23, 2010·Mycopathologia·J A M S Jayatilake
Jul 13, 2011·Frontiers in Microbiology·Ann E JerseLotisha E Garvin
Aug 2, 2012·Antimicrobial Agents and Chemotherapy·Mitchell G ThompsonDaniel V Zurawski
Nov 22, 2012·Obstetrics and Gynecology·Dror MarchaimJack D Sobel
Oct 15, 2013·Current Opinion in Microbiology·Suzanne M Noble
Dec 7, 2013·Frontiers in Cellular and Infection Microbiology·Mélissa Caza, James W Kronstad
Dec 20, 2013·Postȩpy dermatologii i alergologii·Małgorzata BondarykMonika Staniszewska

❮ Previous
Next ❯

Citations

Jun 14, 2019·Frontiers in Cellular and Infection Microbiology·Claudia Simm, Robin C May
Nov 12, 2019·Metallomics : Integrated Biometal Science·Elizabeth W Hunsaker, Katherine J Franz
Sep 12, 2018·Pharmaceuticals·Ana Cordeiro GomesMaria Salomé Gomes
Nov 5, 2019·Frontiers in Cellular and Infection Microbiology·Natalia V KirienkoYou-Hee Cho
Oct 20, 2020·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Roger Gumbau-BrisaMatthias Bierenstiel
Mar 10, 2019·Biochimica Et Biophysica Acta. Proteins and Proteomics·Brian C MonkMikhail V Keniya
Jul 9, 2020·ACS Applied Materials & Interfaces·Srinivas AbbinaJayachandran N Kizhakkedathu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.